Loading...

Gefitinib treatment affects androgen levels in non-small-cell lung cancer patients

Gefitinib, an inhibitor of the epidermal growth factor receptor (EGFR, HER1/ErbB1) tyrosine kinase, has been shown to have clinical activity against non-small-cell lung cancers (NSCLCs), especially in women nonsmokers with adenocarcinomas. The aim of the present study was to clarify the relationship...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Nishio, M, Ohyanagi, F, Horiike, A, Ishikawa, Y, Satoh, Y, Okumura, S, Nakagawa, K, Nishio, K, Horai, T
Format: Artigo
Sprog:Inglês
Udgivet: Nature Publishing Group 2005
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361759/
https://ncbi.nlm.nih.gov/pubmed/15870715
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602585
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!